Catalyst Wire Dossier Catalyst Wire Dossier

Allo-CD7 CAR-T cells

· Nanjing Bioheng Biotech Co., Ltd.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Allo-CD7 CAR-T cells, covering 2025-08-26 to 2025-08-26. Get the full timeline:

Most recent: Clinical Trial Update: A Study on the Safety, Preliminary Efficacy, and Cellular Kinetics of Allo-CD7 CAR-T Cells in T1DM [EARLY_Phase 1]

See pricing